Randomized Phase II Study of Two Doses of Gefitinib in Hormone-Refractory Prostate Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group To determine the maximum outpatient ...
Fifty-three patients with refractory or relapsed neuroblastoma were treated with 18 mCi/kg 131 I-MIBG on a phase I/II protocol. The median whole-body radiation dose was 2.92 Gy. These results ...
Potassium iodide (KI) is a type of iodine a person may receive during a radiation emergency. It works by preventing the thyroid from absorbing a type of radioactive material. KI is a type of medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback